NRBO NeuroBo Pharmaceuticals Inc: Net earnings per one share for the last twelve months

Official company branding of NeuroBo (NRBO)

NeuroBo Pharmaceuticals (NRBO) is developing through R&D projects under the control of an Asian holding company. The trend of the percentage change in EPS YoY TTM demonstrates local dynamics, where 97.90 describes the current status of the metric. However, expansion is hindered by fierce competition with pharma market behemoths and geopolitical complexities regarding patent law and component supplies, which creates risks for the long-term growth of the share price.

NeuroBo (NRBO) - Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

NRBO (NeuroBo): analytical breakdowns and indicator data

- company stock capitalization data:
Fundamental company valuation:NeuroBo Pharmaceuticals, Inc. NRBO
Product sample of NeuroBo Pharmaceuticals Inc

This metric measures the rate of change in net income per share, stripping the financial result of one-time factors. By analyzing the 12-month YoY EPS trend, an investor assesses the efficiency of capital generation. The metric is sensitive to fluctuations in operating expenses and profit volume. For NeuroBo Pharmaceuticals (NRBO), this reflects the cost of outsourcing research to external laboratories. Diversifying contract partners stabilizes this trend.

Competitor analysis for NeuroBo Pharmaceuticals

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. HSDT|PASG: Net earnings per share (EPS TTM)|Neuphoria (NEUP) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ADXN (Addex Therapeutics)|Net earnings per share (EPS TTM) Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Net earnings per share for the last 12 months|PTIX (Protagenic Therapeutics) - Earnings per one share for the last 12 months|Pasithea Therapeutics Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Net earnings per share for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CARA|Net earnings per one share for the last twelve months chromocell.com CHRO|Earnings per share for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LBPH (Longboard Pharmaceuticals Inc)|Net earnings per share (EPS TTM) Marinus Pharma MRNS|nkgenbiotech.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE